BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Zelenectide pevedotin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Zelenectide pevedotin\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06225596-2820@assetmemo.bio
DTSTAMP:20261121T005808Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Zelenectide pevedotin: Phase 2 readout est. (NCT06225596)
DESCRIPTION:Zelenectide pevedotin\, phase 2\, Urothelial Carcinoma.\nStudy:
  Study BT8009-230 in Participants With Locally Advanced or Metastatic Urot
 helial Cancer (Duravelo-2)\nEstimated primary completion: March 2028. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/zelenectide-pevedotin#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0622559
 6
URL:https://assetmemo.bio/drug/zelenectide-pevedotin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06840483-2820@assetmemo.bio
DTSTAMP:20261121T005808Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Zelenectide pevedotin: Phase 2 readout est. (NCT06840483)
DESCRIPTION:Zelenectide pevedotin\, phase 2.\nStudy: Study of Zelenectide P
 evedotin in Participants With Advanced Breast Cancer\nEstimated primary co
 mpletion: 30 June 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/zelenectide-pevedotin#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT06840483
URL:https://assetmemo.bio/drug/zelenectide-pevedotin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07681674-2820@assetmemo.bio
DTSTAMP:20261121T005808Z
DTSTART;VALUE=DATE:20300530
DTEND;VALUE=DATE:20300531
SUMMARY:Zelenectide pevedotin: Phase 2 readout est. (NCT07681674)
DESCRIPTION:Zelenectide pevedotin\, phase 2.\nStudy: Bicycle Continued Acce
 ss Protocol (BiCAP) for Participants Receiving a Bicycle Investigational P
 roduct\nEstimated primary completion: 30 May 2030. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/zelenectide-pevedotin#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07681674
URL:https://assetmemo.bio/drug/zelenectide-pevedotin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
